Position in NVO
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,102,620
+$257,370 QoQ
Shares Held
23,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#508
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rossmore Private Capital holds $82,109,326 across 11 Drug Manufacturers - General names. NVO ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
100,877 | $25,619,731 | |
| 2 | LLY |
ELI LILLY & Co
|
20,769 | $24,910,963 | |
| 3 | ABBV |
AbbVie Inc.
|
46,722 | $11,757,124 | |
| 4 | MRK |
Merck & Co., Inc.
|
57,121 | $7,340,048 | |
| 5 | AZN |
Astrazeneca PLC
|
37,843 | $7,175,789 | |
| 6 | AMGN |
Amgen Inc
|
5,635 | $2,040,546 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
23,000 | $1,102,620 | |
| 8 | NVS |
Novartis AG
|
4,581 | $717,934 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,102,620 | 23,000 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $845,250 | 23,000 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,205,856 | 23,700 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,276,270 | 23,000 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,587,460 | 23,000 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,618,299 | 23,305 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,995,061 | 23,193 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,757,065 | 23,155 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $3,283,020 | 23,000 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,953,200 | 23,000 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,379,350 | 23,000 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,091,620 | 23,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,861,045 | 11,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,830,110 | 11,500 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,556,410 | 11,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,145,745 | 11,500 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,281,445 | 11,500 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,277,075 | 11,500 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,288,000 | 11,500 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,104,115 | 11,500 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $963,355 | 11,500 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $775,330 | 11,500 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $803,275 | 11,500 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $798,445 | 11,500 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $753,020 | 11,500 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $692,300 | 11,500 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||